Competent Cells Market

Competent Cells Market: Cloning to Remain Largest Application of Competent Cells: Global Industry Analysis (2012 - 2016) & Opportunity Assessment (2017 - 2022)

  • 2017-09-21
  • REP-GB-5061
  • 170 pages
  • Format: PDF/PPT/Excel

An Incisive, In-depth Analysis on the Competent Cells Market

This study offers a comprehensive, 360 degree analysis on the Competent Cells market, bringing to fore insights that can help stakeholders identify the opportunities as well as challenges. It tracks the global Competent Cells market across key regions, and offers in-depth commentary and accurate quantitative insights. The study also includes incisive competitive landscape analysis, and provides key recommendations to market players on winning imperatives and successful strategies.

Continued government support, coupled with academic excellence, has propelled the growth of global life science industry. Extensive research studies are accelerating the use of advanced technologies in improving the study of living organisms, and thereby contributing to the development of transformational healthcare through living cells such as competent cells. According to Future Market Insights, the global market for competent cells will expand at a robust CAGR during the forecast period, 2017-2022. A slew of factors are anticipated to influence the dynamics of global competent cells market, which is poised to reach US$ 2,100 Mn value by the end of 2022.

Cloning Applications of Competent Cells to Register Highest Value Share

For performing a number of downstream applications such as mutagenesis and recombinant protein expression, efficient nucleic acid uptake by transformation of competent E. coli has become integral to molecular cloning. Competent cells are customarily used in sequencing and cloning applications, and are relatively referred to as cloning strains. In 2017, over half of the global market for competent cells is anticipated to attain value from sales of these strains. Cloning will remain the sought-after application for competent cells in the global market through 2022.

While cloning strains of competent cells are not suitable for application in protein expressions, the market is pegged to witness a higher traction for this application. In the future, competent cells will be actively used to efficiently express a protein from a provided construct. Choosing a competent cell strain for protein expression application will involve identification of the promoter system being used, and denotation of the required level of promoter control. During the forecast period, revenues procured from protein expression application of competent cells are expected to register the fastest CAGR of 8.4%.

Academic Research Institutes – Largest End-users

In 2017, academic and research institutes across the globe will emerge as the largest end-users of competent cells. Researchers in these institutes study the chemical competency of E. coli cells, and fuel their use through multiple applications. Research institutes are also at the forefront of producing less-expensive chemically competent cells in labs as their synthesis does not entail special equipment and apparatus. Studies conducted on competent cells are primarily directed to increase their use by biotechnology and pharmaceutical companies. By the end of 2022, end-use of competent cells in pharmaceutical and biotechnology companies is anticipated to bring in around US$ 680 Mn in global revenues. These companies will also record a rampant growth in terms of generating revenues in the global competent cells market throughout the forecast period.

Sales of Electrocompetent Cells to Record 8.7% CAGR

The report also anticipates that electrocompetent cells will be registering high revenue growth in the global market through 2022. Electrocompetent transformation of E. coli cells provide highest transformational efficiency, which increases their scope for end-use and application. Moreover, electrocompetent cells do not require a distinct electroporation device for transformation. The report also projects that chemically competent cells will procure largest revenues share on global market in 2017, albeit, their demand is expected to incur a relatively moderate growth compared to electrocompetent cells.

Competent Cells Market: Key Players

Considering the cloning and transformational properties of competent cells, industry leaders in transformational health sciences are actively boosting their presence in the global market. Companies namely, Agilent Technologies Inc., Genescript Biotech Corporation, Bio-Rad Laboratories Inc., Merck & Co Inc., OriGene Technologies, Inc., New England Biolabs Inc., Illumina, Inc., Thermo Fisher Scientific, Inc., QIAGEN N.V., Zymo Research Corporation, and Promega Corporation are anticipated to remain active in expansion of global competent cells market through 2022. These companies are likely to focus on improving the transformational efficiencies of competent cell strains. A common objective for players in the global competent cell market is to increase the reliability of competent cells and make them the coveted choice for automating transformations. 

Competent cells refer to E. coli cells, which comprise altered cell walls to enable assimilation of foreign DNA. Competent cells are broadly used for protein expression and cloning. Advancements in research related to molecular cloning and increasing commercial demand for recombinant proteins and molecular cloned products are some factors impacting growth of the global competent cells market.

In its upcoming research report titled “Competent Cells Market: Global Industry Analysis (2012-2016) & Opportunity Assessment (2017-2022)”, Future Market Insights (FMI) has offered an in-depth analysis of the competent cells market. Historical analysis of the market for past four years is comprehensively compared with the market forecast for the period 2017 to 2022, enabling readers in gaining an understanding of current and future potential for growth of global competent cells market.

Structure of Report

The report commences with an executive summary, which is concise, and delivers a 360-degree view of the competent cells market. In this chapter, the report offers an overview of the market, along with significant and relevant market numbers, which include historical CAGR (2012-2016) and forecast CAGR (2017-2022). The executive summary also renders information about lucrative regions on the basis of largest revenue share, and highest CAGR. The executive summary is followed by a detailed introduction of the market and a brief definition of the product – competent cells.

Moving forward, the report offers analysis of trends, untapped opportunities for market participants, and macroeconomic factors impacting the market growth. Succeeding chapters of the report emphasize on cost structure, product life cycle, supplier list, pricing analysis, and supply chain analysis. The report has incorporated an intensity map, showcasing presence of market participants across specific regions included in the report. 

Market Taxonomy

The report has provided forecast of the global competent cells market on the basis of a segmentation-wise analysis. The global market for competent cells has been segmented based on application, end-user, product type, and region. This chapter of the report contains pertinent market numbers on the basis of revenue comparison, Y-o-Y growth comparision, and market share comparison. On the basis of regions, the report has segmented the market into Middle East & Africa (MEA), Japan, Asia-Pacific excluding Japan (APEJ), Europe, North America, and Latin America. Quantifying the competent cells market across regions is a matter of identifying opportunities & quantifying expectations, instead of rationalizing them post-completion of the forecast period.


Product Type

End User


  • North America

  • Chemically Competent Cells

  • Academic Research Institutes

  • Cloning

  • Latin America

  • Electrocompetent Cells

  • Pharmaceutical & Biotechnology Companies

  • Protein Expression

  • Europe


  • Contract Research Organizations

  • Other Applications

  • Japan




  • APEJ




  • MEA




 Competition Landscape

The last chapter of the report offers information associated with the competition landscape of the market, listing details about global leaders operating in the global competent cells market. The information provided about market participants is in terms of key developments made by these players, product overview, key financials, and company overview. In the competition landscape, the report has also features the SWOT analysis of selected market players. This chapter is an integral part of the report, offering report readers with necessary information related to current market standings of global leaders in the competent cells market, and the way of strategy implementation of these players.

Research Methodology

Future Market Insights’ analysts have leveraged tested and proven research methodologies in order to deduce the overall market size, coupled with contributions made by leading market players. Primary interview have been conducted by FMI’s analysts with industry experts in detail, for collecting authentic data concerning the global competent cells market. This data gathered is further scrutinized and validated, by employing advanced tools for gleaning relevant insights pertaining to the global competent cells market.

COVID -19 : Impact Analysis

Request the coronavirus impact analysis across industries and markets

Request Covid -19 Impact

Get in touch

Harish Tiwari

Global Head - Business Development

Akshay Godge

Client Partner - Global Business Development

Our Clients


See how our work makes an impact.

At FMI, we design strategies that are adaptive, impactful, and implementable.

Request Sample Ask An Analyst Request Special Price Request Methodology